Jia Wei Qingxin Lotus Seed Drink ameliorates epithelial mesenchymal transition injury in diabetic kidney disease via inhibition of JMJD1C/SP1/ZEB1 signaling pathway
This study was the first to demonstrate that QISD might ameliorate DKD-EMT injury by inhibiting the JMJD1C/SP1/ZEB1 signaling pathway. These findings provide strong pharmacologic evidence for the clinical use of QISD in the treatment of DKD.
Authors
- Jiarun Xie
- Anna Zuo
- Haoyu Lin
- Jia Sun (ORCID: https://orcid.org/0000-0001-9617-5865)
- Pei‐Yuan Yang (ORCID: https://orcid.org/0000-0002-8960-6441)
- Yao Wang (ORCID: https://orcid.org/0000-0003-4174-755X)
- Ming Wang (ORCID: https://orcid.org/0000-0002-3258-6961)
- Song Jianda
- Yanyu Luo
- Wenming Lin
- Daijiao Yuan
- Fuhua Jin
Institutions
- Qingdao University (CN)
- Qingdao Municipal Hospital (CN)
- Zhujiang Hospital (CN)
- TCM-Intigrated Cancer Center of Southern Medical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1016/j.phymed.2024.156142
- Citations
- 13
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.04